Le Monde [19 April, 2017]
“Mobilisation contre les maladies tropicales négligées” – “Mobilization against neglected tropical diseases”
Devex [18 April, 2017]
“Strides in progress on neglected tropical diseases as global partners meet”
October 24-26, 2017
Janice Lee, Project Manager Paediatric HIV/HCV, DNDi presented on the paediatric HIV RELIVING Study.
Financial Times [18 April, 2017]
“The long road to elimination of neglected tropical diseases”
[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.
[Seattle, USA – February 14, 2017]
Landmark study proves that “super-boosting” approach counters negative interaction between key HIV and TB drugs
The non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) has released results of a study in South Africa that will make it easier for healthcare workers to treat children living with HIV who are co-infected with tuberculosis.
October 4-6, 2017
Graeme Bilbe, R&D Director, DNDi and Suman Rijal, Director of DNDi Regional Office India took part in the event.
September 26-29, 2017
DNDi Latin America’s Regional Policy Advocacy Consultant, Francisco Viegas, gave a presentation on innovation and access for neglected populations.
Action on Antibiotic Resistance (ReAct) Africa Annual Conference 2017
September 18-19, 2017
DNDi Africa’s Director, Monique Wasunna, gave a presentation on DNDi‘s various programme models.
Ärzte Zeitung [30 January, 2017]
“London Declaration entfaltet ihre Wirkung” – “London Declaration develops its impact”
July 9-14, 2017
São Paulo, Brazil
Charles Mowbray, Head of Discovery, DNDi presented on drug discovery for neglected diseases.
KEMRI Annual Scientific and Health Conference
February 8-10, 2017
Gina Ouattara, Project Coordinator for HIV/HCV, and Kevin Onyango, Project Coordinator for Mycetoma, both from the DNDi Africa office, presented at the event.
Our staff, partners, and stakeholders share their highlights from 2016.
WuXi App Tec [1 December, 2016]
“Harnessing science for the most neglected diseases – A chat with Charles Mowbray, Ph.D., Head of Drug Discovery, DNDi“
The implementation Project for Chagas disease in Colombia is moving forward. After an epidemiological analysis, the partners confirmed the change of the diagnostic algorithm for the country’s pilot projects. With the new algorithm, positive cases for Chagas are confirmed by a simpler procedure test.
devex [18 July, 2016]
“Bringing medicines to the world”
As the International AIDS Conference kicks off in Durban, the Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing ‘4-in-1’ fixed-dose combinations using the World Health Organization (WHO) recommended treatment regimen for infants and young children. DNDi’s update also discusses some promising developments for treatment for children living with both HIV and tuberculosis (TB).
[Paris, France – Le 06 juillet 2016]
La Fondation Mérieux, l’Inserm, l’Institut Pasteur, Réseau CANOPE, MSF, Universcience, le DNDi… Les principaux acteurs français de la lutte contre les maladies infectieuses présentent la série et le webdocumentaire Grandes Tueuses, disponibles en ligne dès maintenant. Conçues comme un outil de sensibilisation pour le grand public et les acteurs de terrain, les 70 vidéos décrivent 14 grandes problématiques de santé publique et sont en open data, en libre accès et libre utilisation. En complément, le webdocumentaire est présenté sur le site d’Allô Docteurs.